A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

被引：0
|
作者：
Congyu Shi
Shan Liu
Xudong Tian
Xiaoyi Wang
Pan Gao
机构：
[1] Sichuan University,State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology
[2] Sichuan University,State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of General and Emergency Dentistry, West China Hospital of Stomatology
来源：
BMC Cancer | / 21卷
关键词：
mutation; Head and neck squamous cell carcinoma; Prognosis; Immunotherapy; Chemotherapy; Therapeutic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
    Li, Yongchao
    Wu, Tinghui
    Gong, Shujuan
    Zhou, Hangzheng
    Yu, Lufei
    Liang, Meiyan
    Shi, Ruijun
    Wu, Zhenhui
    Zhang, Jinpei
    Li, Shuwei
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [32] Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
    Liu, Guohong
    Yuan, Chunjue
    Ma, Jiaojiao
    Pan, Yunbao
    Xu, Haibo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma
    Ying, Kaijun
    Zou, Li
    Wang, Daquan
    Wang, Rao
    Qian, Jun
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (18) : 2699 - 2711
  • [34] The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times
    Eriksen, JG
    Alsner, J
    Steiniche, T
    Overgaard, J
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 (02) : 135 - 142
  • [35] Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
    Sun, Jing
    Fang, Guiqing
    Zuo, Zhibin
    Yu, Xijiao
    Xue, Lande
    Li, Chong
    Li, Shu
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [36] TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma
    Zhang, Xiulei
    Fu, Zhihao
    Zhang, Xiao
    ONCOTARGETS AND THERAPY, 2021, 14 : 4427 - 4437
  • [37] Comprehensive analysis of the prognosis and biological significance of RORβ in head and neck squamous cell carcinoma
    Zheng, Jiawen
    Tang, Hong
    Yang, Yixin
    Yang, Kai
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (02) : 487 - 508
  • [38] Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma
    Feng, Guanying
    Wang, Tianxiao
    Xue, Feifei
    Qi, Yibo
    Wang, Ruixia
    Yuan, Hua
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (12): : 3820 - 3831
  • [39] Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction
    Li, Qun
    Jin, Yangli
    Shen, Zhisen
    Liu, Huigao
    Shen, Yi
    Wu, Zhenhua
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 10117 - 10129
  • [40] Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
    Huang, Minran
    Jin, Jiaoyue
    Zhang, Fanrong
    Wu, Yingxue
    Xu, Chenyang
    Ying, Lisha
    Su, Dan
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
12345